Delirium in the ICU

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

1 comments

Comments 1 - 1 of 1 previous next Post a comment

  • + sheilakomara sheilakomara 2 years ago
    would love to be able to download your presentation, very nice, indeed.
Post a comment
Embed Video
Edit your comment Cancel

2 Favorites

Delirium in the ICU - Presentation Transcript

  1. Delirium in the ICU
    • from witness to criminal
    Dr. Andrew Ferguson MEd FRCA FCARCSI DIBICM FCCP
    • “ The subject of delirium is generally looked upon by the practical physician as one of the most obscure in the chain of morbid phenomena he has to deal with; whilst the frequency of its occurrence under various conditions of the system renders the affection not a little familiar to his eye”
    Gallway MB (1838). Nature and treatment of delirium. Lond Med Gazette 1: 46–49.
  2. Overview
    • What is delirium ?
    • How is it categorised?
    • Why does it matter?
    • Why does it happen?
    • How do we diagnose/monitor it?
    • How do we prevent and treat it?
    • What does it mean for our patients?
  3. What is Delirium?
    • An acute confusional state with
      • Fluctuating mental status
      • Disordered attention
      • Disorganised thinking OR altered consciousness
    • DSM IV definition : “a disturbance of consciousness with inattention accompanied by a change in cognition or perceptual disturbance that develops over a short period (hours to days) and fluctuates with time”
    • Synonyms : ICU psychosis, septic encephalopathy, ICU syndrome, acute brain failure, acute confusional state
  4. How is Delirium Categorised? Hyperactive Hypoactive Mixed 1.6% of cases, “ ICU psychosis ”, agitation, restlessness, “picking”, emotional lability 54.1% % of cases 43.5% of cases, “ encephalopathy ”, often unrecognised, withdrawal, flat affect, apathy, lethargy, decreased responsiveness, may be misdiagnosed as depression
  5. Why does delirium matter?
    • Increased reintubation risk (OR=3)
    • Increased ICU & hospital stay * (up to 10 days extra)
      • Each day in delirium increases risk of longer stay by 20%
    • Increased mortality in ICU & out to 6 months** (OR=3)
      • Each day spent in delirium increases risk of death by 10%
    • Increased ICU & hospital costs ***
    • 10-24% risk of long-term cognitive impairment
    • Increased dementia risk
    • Reduced functional status at 3 & 6 months
    * Ely et al, Intensive Care Med 2001; 27: 1892-1900 ** Ely et al, JAMA 2004; 291: 1753-62 *** Milbrandt et al, CCM 2004; 32: 955-62
  6.  
  7. Why does delirium happen?
    • Higher cortical dysfunction (on functional neuroimaging)
      • Pre-frontal cortex, non-dominant posterior parietal regions, anterior thalamus, basal ganglia, temporal-occipital cortex
    • Neurotransmitter dysfunction
      • Reduced acetylcholine levels – blockade or deficiency
        • Endogenous anticholinergic substances
        • Opiates/hypoxia/inflammation
      • Serotonin fluctuation
      • Dopamine excess
      • Glutamate excess (2 o to IFN-  , LPS, hypoxia, hypoglycaemia)
    • Predisposition (baseline vulnerability)
    • Precipitants (clinical, iatrogenic, organisational risk factors)
  8. Why does delirium happen? Serotonin Acetylcholine Dopamine Opioids & benzo’s 2 o brain infection Decreased cerebral metabolism 1 o intracranial disease Systemic disease Hypoxia Metabolic derangement Withdrawal syndromes Toxins
  9. Risk factors for delirium Van Rompaey Intensive and Critical Care Nursing 2008; 24: 98—107
  10. Age Severity Benzo’s Pun & Ely, Chest 2007; 132: 624–636 Pandharipande et al, Anesthesiology 2006; 104: 21-26
  11. DELIRIUM(S) - causes
    • D Drugs, dementia
    • E Eyes & ears (poor vision and hearing)
    • L Low O 2 states (CHF, COPD, ARDS, MI, PE)
    • I Infection
    • R Retention (urine and stool)
    • I Ictal states
    • U Underhydration/undernutrition
    • M Metabolic upset
    • (S) Subdural, sleep deprivation
  12. I WATCH DEATH
    • I Infection
    • W Withdrawal (alcohol, sedatives, barbiturates etc.)
    • A Acute metabolic (acidosis, alkalosis, electrolytes)
    • T Trauma (closed head injury, haematoma etc.)
    • C CNS pathology (seizures, stroke, encephalitis)
    • H Hypoxia
    • D Deficiencies (thiamine, niacin, B12, folate)
    • E Endocrinopathies (thyroid, glucose, adrenal)
    • A Acute vascular (hypertensive crisis, arrhythmia)
    • T Toxins/drugs
    • H Heavy metals
  13. Diagnosis & monitoring Level of consciousness Content of consciousness
  14. Diagnosis & monitoring
    • Intensive Care Delirium Screening Checklist (ICDSC)
      • 8 items based on data from preceeding 24 hours
      • Score > 4 items = positive for delirium
      • Sensitivity 99%, specificity 64%, inter-observer reliability 94%
      • Simple
    • Confusion Assessment Method for ICU (CAM-ICU)
      • 4 features
      • Altered or fluctuating mental status compared to baseline
      • Inattention (Attention Screening Examination – ASE, visual or auditory recollection of letter or images)
      • Disorganised thinking – 4 Y/N questions + hold up 2 fingers on each hand
      • Altered consciousness – sedation scale e.g. RASS
      • Delirium = 1 AND 2 plus 3 OR 4
  15.  
  16.  
  17. ICDSC
  18. CAM-ICU
  19. Treating delirium
    • Non-pharmacological (most studied outside ICU)
      • Up to 40% risk reduction achieved
      • Repeated reorientation of patients
      • Early mobilisation
      • Visual and hearing aids (and wax removal!)
      • Early catheter, line etc. removal
      • Minimise restraints and sedatives
  20. Treating delirium - haloperidol
      • Typical antipsychotic
      • 2-5 mg iv/po q6H (reduce in elderly)
      • Adverse effects – extrapyramidal, prolonged QTc, torsades (3.8%), neuroleptic malignant syndrome
      • More effective than lorazepam
      • ? mortality reduction in ventilated ICU patients
      • Dopamine blockade + disinhibition of ACh
      • Anti-inflammatory effects
    Girard & Ely, Handbook of Clinical Neurology 2008; 90: chapter 3
  21. Treating delirium – atypical antipsychotics
      • Olanzepine, quetiapine, risperidone
      • Alter multiple neurotransmitters including DA, NA, serotonin, ACh, histamine
      • Suggestion of decreased extrapyramidal side-effects compared to haloperidol
      • As effective as haloperidol
    Girard & Ely , Handbook of Clinical Neurology 2008; 90: chapter 3 Skrobik YK, Bergeron N, Dumont M et al . (2004). Olanzapine vs haloperidol: treating delirium in a critical care set- ting. Intensive Care Med 30: 444–449.107: 341–351. Han CS, Kim YK (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45: 297–301 Breitbart W, Marotta R, Platt M et al. (1996). A double- blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153: 231–237.
  22. Internet Resources
    • www.icudelirium.org

+ ferguafergua, 2 years ago

custom

1690 views, 2 favs, 2 embeds more stats

Overview of recognition and management of delirium more

More info about this document

© All Rights Reserved

Go to text version

  • Total Views 1690
    • 1666 on SlideShare
    • 24 from embeds
  • Comments 1
  • Favorites 2
  • Downloads 89
Most viewed embeds
  • 17 views on http://ccmed.squarespace.com
  • 7 views on https://ccmed.squarespace.com

more

All embeds
  • 17 views on http://ccmed.squarespace.com
  • 7 views on https://ccmed.squarespace.com

less

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

Cancel
File a copyright complaint
Having problems? Go to our helpdesk?

Categories